|
GOLGA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.751800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.653500E-02 |
| Normal-vs-Stage2 |
6.184400E-01 |
| Normal-vs-Stage3 |
2.576200E-01 |
| Normal-vs-Stage4 |
7.521200E-01 |
| Stage1-vs-Stage2 |
4.041200E-01 |
| Stage1-vs-Stage3 |
1.598240E-03 |
| Stage1-vs-Stage4 |
5.035700E-02 |
| Stage2-vs-Stage3 |
1.720430E-01 |
| Stage2-vs-Stage4 |
4.873000E-01 |
| Stage3-vs-Stage4 |
5.153000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.384200E-01 |
| Normal-vs-AfricanAmerican |
9.847400E-01 |
| Normal-vs-Asian |
5.554200E-01 |
| Caucasian-vs-AfricanAmerican |
5.832200E-01 |
| Caucasian-vs-Asian |
8.117400E-01 |
| AfricanAmerican-vs-Asian |
6.217200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.659400E-01 |
| Normal-vs-Female |
7.098700E-03 |
| Male-vs-Female |
7.78530000000721E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.242800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.256000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.554800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.279400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.281200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.620600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.624800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.731500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.036600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.284400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.32599999997019E-06 |
| Normal-vs-Grade 2 |
6.088300E-02 |
| Normal-vs-Grade 3 |
5.914800E-01 |
| Normal-vs-Grade 4 |
2.909400E-01 |
| Grade 1-vs-Grade 2 |
2.022200E-03 |
| Grade 1-vs-Grade 3 |
3.67840000000674E-05 |
| Grade 1-vs-Grade 4 |
2.008700E-04 |
| Grade 2-vs-Grade 3 |
5.124000E-03 |
| Grade 2-vs-Grade 4 |
6.976500E-03 |
| Grade 3-vs-Grade 4 |
4.357000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.006100E-04 |
| Normal-vs-ccB subtype |
1.150990E-01 |
| ccA subtype-vs-ccB subtype |
5.54239998340478E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.445400E-01 |
| Normal-vs-N1 |
5.875200E-01 |
| N0-vs-N1 |
4.337200E-01 |
|
|
